A nanomaterial-based breath test for distinguishing gastric cancer from benign gastric conditions

[1]  Jacques Ferlay,et al.  GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet] , 2013 .

[2]  Ulrike Tisch,et al.  A nanomaterial-based breath test for short-term follow-up after lung tumor resection. , 2013, Nanomedicine : nanotechnology, biology, and medicine.

[3]  Hossam Haick,et al.  Volatile organic compounds of lung cancer and possible biochemical pathways. , 2012, Chemical reviews.

[4]  Ulrike Tisch,et al.  The scent fingerprint of hepatocarcinoma: in-vitro metastasis prediction with volatile organic compounds (VOCs) , 2012, International journal of nanomedicine.

[5]  H. Haick,et al.  Detection of asymptomatic nigrostriatal dopaminergic lesion in rats by exhaled air analysis using carbon nanotube sensors. , 2012, ACS chemical neuroscience.

[6]  H. Haick,et al.  Effect of humidity on nanoparticle-based chemiresistors: a comparison between synthetic and real-world samples. , 2012, ACS applied materials & interfaces.

[7]  H. Haick,et al.  Detection of multiple sclerosis from exhaled breath using bilayers of polycyclic aromatic hydrocarbons and single-wall carbon nanotubes. , 2011, ACS chemical neuroscience.

[8]  H. Haick,et al.  Utility of Resistance and Capacitance Response in Sensors Based on Monolayer-Capped Metal Nanoparticles , 2011 .

[9]  H. Haick,et al.  Diagnosis of head-and-neck cancer from exhaled breath , 2011, British Journal of Cancer.

[10]  A. E. George,et al.  Cholesterol Enhances Helicobacter pylori Resistance to Antibiotics and LL-37 , 2011, Antimicrobial Agents and Chemotherapy.

[11]  Ulrike Tisch,et al.  Classification of breast cancer precursors through exhaled breath , 2011, Breast Cancer Research and Treatment.

[12]  Ulrike Tisch,et al.  Arrays of chemisensitive monolayer-capped metallic nanoparticles for diagnostic breath testing , 2010 .

[13]  W. Miekisch,et al.  Breath biomarkers for lung cancer detection and assessment of smoking related effects--confounding variables, influence of normalization and statistical algorithms. , 2010, Clinica chimica acta; international journal of clinical chemistry.

[14]  Julian King,et al.  Physiological modeling of isoprene dynamics in exhaled breath. , 2010, Journal of theoretical biology.

[15]  Ulrike Tisch,et al.  Nanomaterials for cross-reactive sensor arrays , 2010 .

[16]  Anton Amann,et al.  Methodological issues of sample collection and analysis of exhaled breath , 2010 .

[17]  H. Haick,et al.  Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors , 2010, British Journal of Cancer.

[18]  G. Sun,et al.  Quantitative breath analysis of volatile organic compounds of lung cancer patients. , 2010, Lung cancer.

[19]  Anton Amann,et al.  TD-GC-MS Analysis of Volatile Metabolites of Human Lung Cancer and Normal Cells In vitro , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[20]  W. Miekisch,et al.  Breath gas aldehydes as biomarkers of lung cancer , 2009, International journal of cancer.

[21]  Hossam Haick,et al.  Sniffing the unique "odor print" of non-small-cell lung cancer with gold nanoparticles. , 2009, Small.

[22]  H. Haick,et al.  Diagnosing lung cancer in exhaled breath using gold nanoparticles. , 2009, Nature nanotechnology.

[23]  M. Fiegl,et al.  Noninvasive detection of lung cancer by analysis of exhaled breath , 2009, BMC Cancer.

[24]  Chiao‐Yun Chen,et al.  Differentiation between malignant and benign gastric ulcers: CT virtual gastroscopy versus optical gastroendoscopy. , 2009, Radiology.

[25]  Magdalena Ligor,et al.  Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry , 2009, Clinical chemistry and laboratory medicine.

[26]  Tomas Mikoviny,et al.  Release of volatile organic compounds from the lung cancer cell line NCI-H2087 in vitro. , 2009, Anticancer research.

[27]  Tomotaka Sobue,et al.  The Japanese guidelines for gastric cancer screening. , 2008, Japanese journal of clinical oncology.

[28]  R. Hunt,et al.  Asia–Pacific consensus guidelines on gastric cancer prevention , 2008, Journal of gastroenterology and hepatology.

[29]  Hermann Brenner,et al.  Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. , 2007, The Lancet. Oncology.

[30]  Anton Amann,et al.  Lung cancer detection by proton transfer reaction mass-spectrometric analysis of human breath gas , 2007 .

[31]  D. Vos,et al.  Furfural and Derivatives , 2007 .

[32]  David Smith,et al.  Breath analysis: the approach towards clinical applications. , 2007, Mini reviews in medicinal chemistry.

[33]  T. Gotoda,et al.  Detection of early gastric cancer: misunderstanding the role of mass screening , 2006, Gastric Cancer.

[34]  Hirofumi Nakayama,et al.  Molecular-pathological prognostic factors of gastric cancer: a review , 2005, Gastric Cancer.

[35]  W. Miekisch,et al.  Diagnostic potential of breath analysis--focus on volatile organic compounds. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[36]  D. Roder,et al.  The epidemiology of gastric cancer , 2002, Gastric Cancer.

[37]  J. Brezmes,et al.  Quantitative analysis of NO2 in the presence of CO using a single tungsten oxide semiconductor sensor and dynamic signal processing. , 2002, The Analyst.

[38]  C. Haglund,et al.  CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers. , 2002, Anticancer research.

[39]  R. Cataneo,et al.  Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study , 1999, The Lancet.

[40]  Re-evaluation of some organic chemicals, hydrazine and hydrogen peroxide. Proceedings of the IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, France, 17-24 February 1998. , 1999, IARC monographs on the evaluation of carcinogenic risks to humans.

[41]  N. Talley,et al.  Gastroscopy is incomplete without biopsy: clinical relevance of distinguishing gastropathy from gastritis. , 1995, Gastroenterology.

[42]  M. Phillips,et al.  Metabolic and environmental origins of volatile organic compounds in breath. , 1994, Journal of clinical pathology.

[43]  P. Sobotka,et al.  Pentane and isoprene in expired air from humans: gas-chromatographic analysis of single breath. , 1994, Clinical chemistry.

[44]  G. Tytgat.  The Sydney System: Endoscopic division. Endoscopic appearances in gastritis/duodenitis , 1991, Journal of gastroenterology and hepatology.

[45]  H. Hiller.  In: Ullmann''''s Encyclopedia of Industrial Chemistry , 1989 .

[46]  H. J. O’neill,et al.  A computerized classification technique for screening for the presence of breath biomarkers in lung cancer. , 1988, Clinical chemistry.

[47]  H. J. O’neill,et al.  Volatile organic compounds in exhaled air from patients with lung cancer. , 1985, Clinical chemistry.

[48]  P. Colletti,et al.  Double-contrast barium meal and upper gastrointestinal endoscopy. A comparative study. , 1984, Annals of internal medicine.

[49]  G. Steele.  Cancer: Principles and Practice of Oncology , 1983 .

[50]  C. McConkey,et al.  Cancer of the stomach. , 1989 .

[51]  J. Higginson,et al.  International Agency for Research on Cancer. , 1968, WHO chronicle.

[52]  E. Benedict,et al.  Correlation of gross gastroscopic findings with gastroscopic biopsy in gastritis. , 1956, The New England journal of medicine.

[53]  L. Simon,et al.  Cancer of the stomach. , 1951, Connecticut state medical journal.

[54]  F. Wilcoxon.  Individual Comparisons by Ranking Methods , 1945 .